Live news: Novo Nordisk raises guidance as Ozempic and Wegovy sales boom – Financial Times

by

  1. Live news: Novo Nordisk raises guidance as Ozempic and Wegovy sales boom  Financial Times
  2. Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar  CNBC
  3. Wegovy Pushes Novo Nordisk (NVO) Market Value Above Denmark GDP  Bloomberg
  4. Novo Nordisk hikes FY outlook as demand for weight-loss drug Wegovy soars  Reuters
  5. Novo Nordisk ADR Shows Market Leadership With Jump To 95 RS Rating  Investor’s Business Daily
  6. View Full Coverage on Google News

Leave a Comment